Oil-Free Daily Hydration SPF 15
- Manufacturer
- Boscia LLC | Englewood Lab, Inc.
- Effective date
- 2025-01-31
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 9
- Source
- full-release
- Hydrated at
- 2026-06-01 00:54:10
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose Octinoxate 5% Sunscreen Avobenzone 3% Sunscreen
OTC - PURPOSE SECTION
Use Helps prevent sunburn.
Use
Helps prevent sunburn.
WARNINGS SECTION
Warnings For external use only.
OTC - WHEN USING SECTION
Avoid direct contact with eyes. If contact occurs, rinse gently with water.
OTC - STOP USE SECTION
Discontinue use and consult a physician immediately if any adverse reaction occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
OTHER SAFETY INFORMATION
In case of accidental ingestion, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions Apply small amount in AM to cleansed and toned face as last skincare step.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Water, Butylene Glycol, Silica, Glycerin, Polyglyceryl-10 Stearate, Pentylene Glycol, Simmondsia Chinensis (Jojoba) Leaf Extract, Epilobium Angustifolium Flower/leaf/stem Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract, Algae Extract, Hydrolyzed Yeast Extract, Arctium Lappa Root Extract, Phellodendron Amurense Bark Extract, Hydrogenated Rapeseed Alcohol, Hydroxyethylcellulose, Sclerotium Gum, Aluminum Hydroxide, Potassium Phosphate, Citrus Aurantium Amara (Bitter Orange) Flower Extract, Zinc Oxide, Titanium Dioxide.
DESCRIPTION SECTION
Preservative-free. Dermatologist tested. Non-comedogenic. Alcohol-free, pH balanced, 100% natural fragrance and color, no animals testing and no animal ingredients. An oil-free moisturizer that hydrates the skin, minimizes pores and providers broad spectrum SPF 15. Polysaccharide provides essential moisture, silica powder controls excessive oil while wine Yeast and Marine Complex help protect against external elements.
www.boscia.net B105-11 Distributed by boscia LLC. Irvine, CA 92614 Made in Japan U8-2
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
boscia Oil-free Daily Hydration SPF 15 For normal to oily skin Preservative-free 1.4 fl oz/40 ml
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
www.boscia.net B105-11 Distributed by boscia LLC. Irvine, CA 92614 Made in Japan U8-2
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76151-105-11 | 2025-02-01 | C162847 | 48780-1 | 2cef2736-62b4-d83d-e063-dadaa90ab31f | Oil-Free Daily Hydration SPF 15 |
| 76151-105-52 | 2025-02-01 | C162847 | 48780-1 | 2cef2736-62b4-d83d-e063-dadaa90ab31f | Oil-Free Daily Hydration SPF 15 |
| 76151-105-11 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-62b4-d83d-e063-dadaa90ab31f | Oil-Free Daily Hydration SPF 15 |
| 76151-105-52 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-62b4-d83d-e063-dadaa90ab31f | Oil-Free Daily Hydration SPF 15 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76151-105-11 | Oil-Free Daily Hydration SPF 15 | 40 mL in 1 TUBE | CREAM | 40 | 9 | |
| 76151-105-52 | Oil-Free Daily Hydration SPF 15 | 15 mL in 1 TUBE | CREAM | 15 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| ARCTIUM LAPPA ROOT | INACTIVE INGREDIENT | 597E9BI3Z3 | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| CITRUS AURANTIUM FLOWER | INACTIVE INGREDIENT | O730ZX2Z83 | 1 | |
| EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP | INACTIVE INGREDIENT | 08H094218D | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | 1 | |
| PENTYLENE GLYCOL | INACTIVE INGREDIENT | 50C1307PZG | 1 | |
| PHELLODENDRON AMURENSE BARK | INACTIVE INGREDIENT | PBG27B754G | 1 | |
| POTASSIUM PHOSPHATE | INACTIVE INGREDIENT | B7862WZ632 | 1 | |
| ROSEMARY | INACTIVE INGREDIENT | IJ67X351P9 | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 1 |
Products#
Every source-derived product name is available through these pages.
- Oil-Free Daily Hydration SPF 15
- OCTINOXATE, AVOBENZONE
- WATER
- BUTYLENE GLYCOL
- SILICON DIOXIDE
- GLYCERIN
- PENTYLENE GLYCOL
- EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP
- ROSEMARY
- ARCTIUM LAPPA ROOT
- PHELLODENDRON AMURENSE BARK
- HYDROXYETHYL CELLULOSE (140 CPS AT 5%)
- ALUMINUM HYDROXIDE
- POTASSIUM PHOSPHATE
- CITRUS AURANTIUM FLOWER
- ZINC OXIDE
- TITANIUM DIOXIDE
- OCTINOXATE
- AVOBENZONE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 76151-105 | 76151-105-52, 76151-105-11 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SYRUP / ORAL | 100 mg/5ml | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET / ORAL | 2 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, FILM COATED / ORAL | 1 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM / BUCCAL | 55 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET / ORAL | 2 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SOLUTION / ORAL | 1867 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM / BUCCAL | 55 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SOLUTION / ORAL | 1867 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | CAPSULE / ORAL | 20 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM, SOLUBLE / BUCCAL | 161 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SUSPENSION / ORAL | 1200 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, FILM COATED / ORAL | 1 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM, SOLUBLE / BUCCAL | 161 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SYRUP / ORAL | 100 mg/5ml | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | CAPSULE / ORAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SYRUP / ORAL | 100 mg/5ml | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SUSPENSION / ORAL | 1200 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SOLUTION / ORAL | 1867 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, FILM COATED / ORAL | 1 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | CAPSULE / ORAL | 20 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM, SOLUBLE / BUCCAL | 161 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CREAM / TOPICAL | 5 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SUSPENSION / ORAL | 1200 mg | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CREAM / TOPICAL | 5 %w/w | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET / ORAL | 2 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CREAM / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM / BUCCAL | 55 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| HYDROXYETHYL CELLULOSE (140 CPS AT 5%) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oil-Free Daily Hydration SPF 15 | OCTINOXATE, AVOBENZONE | Boscia LLC | ec322ae5-ab03-4c7b-9c6d-0bda3327c72a | 2025-01-31 | Warnings | 76151-105-52 76151-105-11 76151-105 76151010511 76151010552 2d025da2-1f3a-2062-e063-6294a90ab9e9 ec322ae5-ab03-4c7b-9c6d-0bda3327c72a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

